Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conception to obtain hematopoietic stem cells.

John A Robertson, Jeffrey P Kahn, John E Wagner

    The Hastings Center Report
    |June 28, 2002
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    CSF GAG non-reducing ends in MPS IH after peripheral and brain-penetrating therapies: A model comparing IV non-targeted ERT and HCT.

    Molecular therapy. Advances·2026
    Same author

    Tracking Cytopenias in <i>FANCA</i>-deficient Fanconi Anemia.

    medRxiv : the preprint server for health sciences·2025
    Same author

    BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes.

    American journal of human genetics·2025
    Same author

    Bright-Line Policy and the Future of the Fourteen-Day Rule.

    The Hastings Center report·2025
    Same author

    Research Communication: Prevalence of Asymptomatic Premalignant Oesophageal Lesions in Patients With Fanconi Anaemia.

    Alimentary pharmacology & therapeutics·2025
    Same author

    G-quadruplexes as a source of vulnerability in BRCA2<i>-</i>deficient granule cell progenitors and medulloblastoma.

    Proceedings of the National Academy of Sciences of the United States of America·2025
    Same journal

    Harm Reduction as an Alternative to Mandated Drug Treatment.

    The Hastings Center report·2026
    Same journal

    Rethinking Mandated Drug Treatment: Why Expanding Freedom Requires Structural Drug Policy Reform.

    The Hastings Center report·2026
    Same journal

    Banning Gender-Affirming Treatment for Minors: The Supreme Court Speaks.

    The Hastings Center report·2026
    Same journal

    Making the Move to a Learning System of Research Ethics.

    The Hastings Center report·2026
    Same journal

    Musical Performance and Biomedical Human Enhancement: Ethnographic Perspectives on Bioethical Questions.

    The Hastings Center report·2026
    Same journal

    Transformed but Not Cured: The Ethics of Describing Gene-Editing Therapy for Sickle Cell Disease.

    The Hastings Center report·2026
    See all related articles

    Parents may conceive a child for stem cell donation to a sibling. Genetic testing, including prenatal screening and selective abortion, can be used to ensure a compatible tissue match for treatment.

    Area of Science:

    • Medical Ethics
    • Genetics
    • Reproductive Technologies

    Background:

    • Sibling stem cell transplants offer life-saving treatment options for various diseases.
    • Ensuring a close human leukocyte antigen (HLA) match is critical for transplant success and minimizing rejection.
    • Advances in reproductive technologies present new possibilities for managing genetic compatibility.

    Purpose of the Study:

    • To explore the ethical considerations surrounding conception for the purpose of stem cell donation.
    • To examine the role of preimplantation and prenatal genetic testing in selecting for tissue compatibility.
    • To discuss the implications of using selective abortion to achieve a desired genetic match for a sibling.

    Main Methods:

    • Review of current medical literature on stem cell transplantation and genetic screening.
    Keywords:
    Genetics and Reproduction

    Related Experiment Videos

  • Analysis of ethical frameworks related to reproductive choices and medical interventions.
  • Discussion of the technical aspects of preimplantation genetic diagnosis (PGD) and prenatal diagnosis.

    • Main Results:

    • Conceiving a child for stem cell donation is a complex decision with significant ethical dimensions.
    • Preimplantation genetic diagnosis (PGD) and prenatal testing can identify embryos with specific HLA types.
    • Selective abortion may be employed to terminate pregnancies with non-matching embryos, raising profound moral questions.

    Conclusions:

    • The use of reproductive technologies for HLA matching presents a unique intersection of medical necessity and ethical debate.
    • Balancing the needs of a sick child with the rights and welfare of a potential donor child requires careful consideration.
    • Societal and ethical guidelines are needed to navigate these complex reproductive and medical choices.